Luteal Phase of Menstrual Cycle May Be Key Time to Quit Smoking

Share this content:
Luteal Phase of Menstrual Cycle May Be Key Time to Quit Smoking
Luteal Phase of Menstrual Cycle May Be Key Time to Quit Smoking

THURSDAY, June 2, 2016 (HealthDay News) -- Certain weeks of a woman's menstrual cycle may be better than others for quitting smoking, according to a study published online May 10 in Biology of Sex Differences.

The new study included 38 women smokers, ages 21 to 51, who were not taking hormonal contraceptives. They underwent scans to assess how regions of the brain that help control behavior are functionally connected to regions of the brain that signal reward.

Some participants were in the follicular phase of their menstrual cycle, while others were in the luteal phase. Those in the follicular phase had reduced functional connectivity between the two key regions of the brain. This could make it harder to say no when attempting to quit, the researchers suggested.

"The results from this study become extremely important as we look for more ways to help the over 40 million individuals in the United States alone addicted to cigarettes," senior author Teresa Franklin, Ph.D., a research associate professor of neuroscience in psychiatry at the University of Pennsylvania in Philadelphia, said in a university news release. "When we learn that something as simple as timing a quit date may impact a woman's cessation success, it helps us to provide more individualized treatment strategies for individuals who are struggling with addiction."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »